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Staphylococcus aureus is a worldwide pathogen that colonizes the human nasal
cavity and is a major cause of respiratory and cutaneous infections. In the nasal
cavity, S. aureus thrives with high concentrations of nitric oxide (NO) produced by the
innate immune effectors and has available for growth slow-metabolizing free hexoses,
such as galactose. Here, we have used deep sequencing transcriptomic analysis
(RNA-Seq) and 1H-NMR to uncover how S. aureus grown on galactose, a major
carbon source present in the nasopharynx, survives the deleterious action of NO. We
observed that, like on glucose, S. aureus withstands high concentrations of NO when
using galactose. Data indicate that this resistance is, most likely, achieved through a
distinct metabolism that relies on the increased production of amino acids, such as
glutamate, threonine, and branched-chain amino acids (BCAAs). Moreover, we found
that under NO stress the S. aureus α-acetolactate synthase (ALS) enzyme, which
converts pyruvate into α-acetolactate, plays an important role. ALS is proposed to
prevent intracellular acidification, to promote the production of BCAAs and the activation
of the TCA cycle. Additionally, ALS is shown to contribute to the successful infection of
murine macrophages. Furthermore, ALS contributes to the resistance of S. aureus to
beta-lactam antibiotics such as methicillin and oxacillin.
Keywords: Staphylococcus aureus, nitrosative stress, bacterial metabolism, α-acetolactate synthase (ALS),
nuclear magnetic resonance (NMR)
INTRODUCTION
Staphylococcus aureus is an opportunistic human pathogen that is persistently found in the
epithelial cells of the nasal cavity of patients suffering recurrent sinusitis (Weidenmaier et al.,
2012). Even in the absence of symptoms, the staphylococcal nasal carriage is a known risk
factor as S. aureus exhibits high capacity to evade and thwart the innate and adaptive immune
responses. Moreover, repeated staphylococcal infections can evolve to life-threatening diseases,
such as endocarditis, bloodstream infection, and sepsis (Foster, 2005; Thammavongsa et al., 2015).
Abbreviations: ALS, α-acetolactate synthase; BCAAs, branched-chain amino acids; EMP, Embden-Meyerhof-Parnas;
L-NMMA, NG-monomethyl-L-arginine acetate salt; MRSA, methicillin-resistant Staphylococcus aureus; NMR, nuclear
magnetic resonance; NO, nitric oxide; PDHC, pyruvate dehydrogenase complex; PFL, pyruvate formate-lyase; PPP, pentose
phosphate pathway; RNA-Seq, RNA-Sequencing; TCA, tricarboxylic acid cycle.
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Unfortunately, antibiotic resistant S. aureus strains are
commonly found not only in hospital settings but also in
the community, and many strains show resistance to the last
generation of antibiotics.
Staphylococcus aureus is a facultative anaerobe that besides the
respiratory chain has active Embden-Meyerhof-Parnas (EMP),
pentose phosphate pathway (PPP), and citric acid cycle (TCA)
pathways (Figure 1). As for other pathogens, the synthesis
and acquisition of certain nutrients are critical to support the
infection capacity of S. aureus, glucose being one of the preferred
carbon sources of this bacterium. However, in the nasal cavity
the glucose levels have been proposed to be substantially lower
than those determined in human plasma, and in this niche,
disaccharides and other free hexoses are accessible (Krismer et al.,
2014). In particular, galactose is one of the major carbohydrates
present in the mucus mucins that coat the nasopharyngeal
epithelium of the nasal cavity, and studies done with the nasal
colonizer S. pneumoniae showed that: (i) galactose is released
by hydrolysis of mucins promoted by bacterial exoglycosidases;
(ii) free galactose is abundantly present in the nasal lavage fluid,
whether healthy individuals carry or not the pneumococcus; and
(iii) glucose was not detected in S. pneumoniae carriers and
non-carriers (King, 2010; Blanchette et al., 2016).
In the nose and paranasal sinuses epithelium, the inducible
NO synthase, which is expressed in cells of the innate
immune system, generates NO. This molecule has antibacterial
and cilia-stimulating properties playing a central role in the
host immune defenses (Lanz et al., 2008). The infection of
human phagocytes by pathogens like S. aureus stimulates the
NO production. The antimicrobial properties of NO and its
derivatives, known as the reactive nitrogen species (RNS), rely
on several damaging effects (Richardson et al., 2006; Robinson
et al., 2014). Yet, in general, pathogens resist NO through
the activation of detoxifying enzymes, repairing proteins and
complex metabolic adaptations, and S. aureus has an unique
ability to thrive in NO rich environments (Gonçalves et al., 2006;
Richardson et al., 2008; Tavares et al., 2009; Fuller et al., 2011;
Nobre and Saraiva, 2014).
The preferential glycolytic carbon sources of S. aureus in the
presence of high NO concentrations are hexoses (e.g., glucose and
mannose) (Vitko et al., 2015), and NO-exposed glucose-grown
cells of S. aureus use glycolysis (EMP) as the primary central
metabolic pathway (Hochgräfe et al., 2008; Richardson et al.,
2008; Fuller et al., 2011; Crooke et al., 2013; Vitko et al., 2015;
Spahich et al., 2016). In contrast, gluconeogenic or non-glycolytic
carbon sources (e.g., glycerol, fatty acids, amino acids) fail
to provide resistance to NO, as this compound impairs the
respiratory chain and partially inhibits the PDHC and the PFL
activities (Richardson et al., 2008; Vitko et al., 2015) (Figure 1).
The fluctuating glucose levels occurring in the nasal cavity implies
that S. aureus has to resort to other carbon sources, which led
us to examine how S. aureus sustains NO stress when utilizing
other hexoses available in the nasal niche (King, 2010; Krismer
et al., 2014; Blanchette et al., 2016). In particular, galactose is
important for the colonization of S. aureus, as studies have shown
that: (i) S. aureus binds human nasal galactose rich mucins
during colonization (Shuter et al., 1996); (ii) S. aureus binds
galactose molecules in host glycoproteins (Sakarya et al., 2010);
(iii) the S. aureus tagatose 6-phosphate pathway is essential for
the catabolism of lactose/galactose, which are sugars present
in milk and derivative products (Miallau et al., 2007); and
(iv) the malfunctioning of the S. aureus tagatose 6-phosphate
pathway leads to accumulation of the dietary D-galactose causing
bacterial cell death (Miallau et al., 2007). While in many
bacteria, galactose is predominantly metabolized through the
Leloir pathway, in S. aureus the galactose breakdown occurs
through the tagatose 6-phosphate pathway. In this bacterium,
galactose is transported and phosphorylated via a galactose
phosphotransferase system and converted into the glycolytic
intermediates DHAP and GAP (Figure 1). In general, the tagatose
6-phosphate pathway is less efficient than the Leloir pathway for
the catabolism of galactose, mainly due to the low-affinity for
galactose of the phosphotransferase systems and thus, to the slow
transport/consumption of the sugar (Neves et al., 2010). In this
work, we have analyzed for the first time the effect of NO on
cells grown on galactose. We report that although considered a
slow-metabolizing sugar, galactose ensures growth of S. aureus in
the presence of NO by diverting its metabolism to the production
of specific amino acids via activation of several enzymes, namely
the ALS. In this work, this enzyme is shown to be important for
the protection of S. aureus against NO and antibiotics.
MATERIALS AND METHODS
Bacterial Strains and Growth Conditions
Staphylococcus aureus JE2, a plasmid-cured derivative of the
community-associated methicillin-resistant USA300 LAC strain,
and the JE2 alsS transposon mutant (NE1397, JE2 alsS::8N6;
EmR) of the Nebraska Transposon Mutant Library (UNMC)
were obtained from the Network on Antimicrobial Resistance
in S. aureus (NARSA, Chantilly, VA, United States). The alsS
mutation was confirmed by PCR according to the Nebraska-
UNMC instructions1, and using the following primers: 5′-GCT
TTTTCTAAATGTTTTTTAAGTAAATCAAGTAC-3′ and 5′-
CATCAAAGTATTGATAATGCTGCG-3′ (alsS-specific).
Routinely, S. aureus was grown aerobically at 37◦C and
150 rpm in TSB broth (Difco), and when required, erythromycin
was added at 10 µg mL−1. For the transcriptomic and
metabolic studies, S. aureus was cultured in chemically defined
medium (CDM) containing glucose or galactose as carbon source
(20 mM), phosphate buffer, trace minerals, vitamins, nucleobases,
nitrogen and sulfur sources and amino acids (Ferreira et al.,
2013). The nasal synthetic medium (SNM3), described by
Krismer et al. (2014), was also used for the analysis of extracellular
metabolites by 1H-NMR. However, to ensure a metabolite
concentration detectable by 1H-NMR, glucose was supplemented
at higher concentrations (10 mM). All media used for the NMR
studies contained no paramagnetic ions to avoid interference
with the spectral quality and allow detection of metabolites.
The spermine NONOate (30–40 mM), that was freshly
prepared in 0.01 M NaOH and kept protected from light, was
1http://app1.unmc.edu/fgx/methods.html
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FIGURE 1 | Schematic representation of metabolic pathways of Staphylococcus aureus glucose and galactose catabolism. Galactose is catabolized in the tagatose
6-phosphate pathway into the glycolytic intermediates DHAP and GAP. DHAP and GAP originated from galactose and glucose are oxidized to pyruvate in the EMP
(glycolysis) pathway, which can be reduced to lactate, α-acetolactate and/or acetyl-CoA. Acetyl-CoA can be converted to acetate, to generate ATP, and ethanol.
Alternatively, acetyl-CoA can be used to produce citrate for the citric acid cycle (TCA cycle). Under aerobic conditions, the NADH molecules formed in the EMP and
TCA cycle are oxidized in the respiratory chain, thereby restoring the redox balance, and producing ATP. Proposed pathways were reconstructed based on genome
information (http://www.ncbi.nlm.nih.gov/genomes/lproks.cgi), literature and database surveys (KEGG, MetaCyc). Inside boxes are the end products of pyruvate
metabolism. Inside the black box is the ALS enzyme. AAs, amino acids; ACS, acetyl-CoA synthetase; ADH, bifunctional acetaldehyde-CoA/alcohol dehydrogenase;
ALDC/AR, α-acetolactate decarboxylase/acetoin reductase; ALS, α-acetolactate synthase; BCAAs, branched-chain amino acids; DHAP, dihydroxyacetone
phosphate; FBP, fructose 1,6-bisphosphate; F6P, fructose 6-phosphate; Gal6P, galactose 6-phosphate; GAP, glyceraldehyde 3-phosphate; G6P, glucose
6-phosphate; LDH, lactate dehydrogenase; LQO, lactate-quinone oxidoreductase; PDHC, pyruvate dehydrogenase complex; PFL, pyruvate formate-lyase; 6-PG,
6-phosphogluconate; PPP, pentose phosphate pathway; PTA/ACK, phosphotransacetylase/acetate kinase; OAA, oxaloacetate; TBP, tagatose 1,6-bisphosphate;
T6P, tagatose 6-phosphate.
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used as a NO donor since its half-life (∼39 min at 37◦C) is similar
to the S. aureus cellular doubling time.
Cultures at an initial OD600 of 0.05–0.1 were prepared by
addition to fresh medium of pre-cultured cells harvested at the
exponential phase (OD600 of 1). Cells at an OD600 of 0.4, were left
untreated or exposed to spermine NONOate (250 µM, Sigma),
and growth was monitored hourly.
RNA-Sequencing Analysis
Staphylococcus aureus JE2 cells grown on galactose-CDM to an
OD600 of 0.4 were treated with 250 µM spermine NONOate
(or left untreated, the control sample), and harvested after
3 h. Total RNA was isolated from two biologically independent
samples following the previously described procedures (Carvalho
et al., 2011). RNA samples were analyzed in an Ion ProtonTM
Sequencer by the PrimBio company (Primbio Research Institute,
Innovation Center, Eagleview, Philadelphia, PA, United States).
The transcriptome was analyzed by high-resolution RNA-Seq,
and the statistical and functional data analysis was done with
the Webserver Pipeline T-Rex (de Jong et al., 2015) and Gene
Set Enrichment Analysis for prokaryotes (GSEA-Pro) web tool2.
RNA-Seq data was deposited at Gene Expression Omnibus
(GEO) under the accession number GSE99563. Genes were
considered with a significantly modified expression for adjusted
P-values ≤ 0.05 and fold changes of ≥ 2 or ≤ 0.5.
The RNA-Seq data was confirmed by real-time quantitative
reverse transcription–polymerase chain reaction (qRT-PCR). For
these experiments, S. aureus was grown as described above for
the RNA-Seq studies, and the total RNA was extracted from
cells with the High Pure RNA Isolation Kit (Roche), and further
purified by DNase treatment with the Turbo DNA-freeTM Kit
(Ambion R©). The absence of chromosomal DNA in RNA samples
was confirmed by PCR using oligonucleotides for the S. aureus
16S gene (Supplementary Table S1). RNA concentration and
purity was determined by gel electrophoresis and in a NanoDrop
2000c UV-Vis Spectrophotometer (ThermoScientific). Total
RNA (∼3 µg) served to synthesize cDNA by means of
the Transcriptor High Fidelity cDNA synthesis Kit (Roche).
Real-time qRT-PCR reactions containing ∼300 ng cDNA
template, 0.5 µM gene-specific oligonucleotides (Supplementary
Table S1), H2O PCR-grade and LightCycler R© 480 CYBR Green
Master Mix in 20 µL were carried out in a Roche LightCycler
LC480 Instrument following the LightCycler R©480 SYBR Green I
Master Kit manufacturer’s instructions (Roche). The expression
ratios of the selected genes were normalized relative to S. aureus
16S rRNA reference cDNA, whose expression does not vary
under the tested conditions, and calculated by the 2−11CT
method (Livak and Schmittgen, 2001). The data are an average
of two independent biological samples.
Quantification of Extracellular
Metabolites by 1H-NMR
Cells were grown on galactose-CDM, glucose-CDM and in the
nasal synthetic medium to an OD600 = 0.4 and treated with
250 µM spermine NONOate (or left untreated, the control
2http://pepper.molgenrug.nl/index.php/gsea-pro
sample), and harvested 1 and 3 h later. After centrifugation
(11800 × g for 2 min) and filtering (0.22 µm Pall filters),
the supernatants were stored at −20◦C and later used for the
1H-NMR studies. Extracellular metabolites were quantified on
a Bruker AVANCE II500 MHz spectrometer (Bruker BioSpin
GmbH) operated by TOPSPIN software using a 5 mm BBIXYZ
high resolution probe head, at 16◦C, and standard Bruker pulse
programs. Spectra were referenced to the resonance of externally
added trimethylsilyl propionate (TSP), designated at 0 ppm.
Resonances were assigned by addition to the supernatants
of pure compounds and comparison with data available in the
literature (Carvalho et al., 2011). Concentrations were calculated
from the areas of the resonances of the 1H-NMR spectra
considering the TSP resonance area, and using an appropriate
resonance saturation correction factor (Carvalho et al., 2011).
The metabolites concentration was normalized to the OD600,
measured for each condition.
Determination of NADP+/NADPH Ratios
Extraction Method
Cell cultures (5–10 mL) harvested 3 h after the NO addition were
pelleted (11800 × g, 2 min), immediately flash frozen into liquid
nitrogen and stored at −20◦C for the next-day analyses. For
extraction of NADP+ and NADPH, the pellets were resuspended
in 0.4 N HClO4 and 0.4 N KOH, respectively, incubated on ice
for 15 min, and heated at 60◦C for 7 min. The resulting extracts
were cooled on ice for 10 min, and the cells debris were pelleted at
3000× g for 10 min for the NADP+ extraction, and at 10,000× g
for 15 min for NADPH. The extracts were filtered and neutralized
by slow addition of NaOH or HCl (2–5 M), and kept on ice (based
on Lilius et al., 1979).
Cycling Reaction
NADPH was enzymatically converted to NADP+ following the
procedure described by Vaseghi et al. (1999), and the NADP+
concentration was assayed by the enzymatic cycling method
(Vaseghi et al., 1999) with minor modifications. Briefly, a
reaction mixture containing 0.1 M bicine, 0.1 M nicotinamide,
1 mM PES (phenazine ethosulfate), 4.2 mM MgSO4, 12.7 mM
G6P (glucose 6-phosphate) and dinucleotide extracts in a final
volume of 250 µL was prepared. The reaction was initiated by
addition of glucose 6-phosphate dehydrogenase (G6PDH) and
thiazoylyl blue tetrazolium bromide to final concentrations of
2.8 U and 0.25 mM, respectively. Water was used as blank
and standard curves were obtained with β-NADP+ (Sigma).
Reactions were monitored at 570 nm, for 30 min, using a
Multiskan GO Microplate Spectrophotometer (Thermo Fisher
Scientific).
Macrophage Assays
Murine macrophages J774A.1 (LGC Promochem) were cultured
on 24-well plates, containing Dulbecco’s modified Eagle medium
(31966 – DMEM, Gibco) supplemented with 4.5 g L−1
glucose, 110 mg L−1 sodium pyruvate, 862 mg L−1 glutamine,
15 mg L−1 phenol red, 10% fetal bovine serum, and 50 µg mL−1
streptomycin, and incubated in a 5% CO2 containing atmosphere
(BINDER CO2 incubator, United States) at 37◦C, for 24 h. Prior
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to infection, macrophages were activated by incubation (5 h) with
IFN-γ (1 µg mL−1) and LPS (5 µg mL−1), both from Sigma.
Staphylococcus aureus wild type and alsS mutant were grown
aerobically in LB to an OD600 of 0.4–0.5, washed three times
with PBS, and resuspended in antibiotic-free DMEM medium
(Gibco) to an initial bacterial concentration of about 1× 107 CFU
mL−1. Bacteria were used to infect macrophages at a MOI of ∼5
and, after 30 min the extracellular bacteria were eliminated by a
10 min treatment with DMEM supplemented with 50 µg mL−1
gentamicin. Macrophages were washed with PBS and fresh
DMEM (1 mL) was added, followed by a 5 h incubation. When
required, 800 µM L-NMMA (Sigma) was added to DMEM to
promote inhibition of the murine macrophage inducible NO
synthase (iNOS). Macrophages were lysed with 2% saponin,
and the number of intracellular bacteria determined by CFU
counting.
The NO accumulation in the supernatants of the macrophages
cell cultures, which reflects the iNOS activity, was assessed by
measuring nitrite by the Griess method, which uses sodium
nitrite (Merck) as standard.
Determination of Minimal Inhibitory
Concentration
Minimal inhibitory concentrations (MICs) were carried out by
the broth tube dilution test. Briefly, 96-well plates containing TSB
were inoculated to an initial OD600 of 0.01 with exponentially
TSB-grown cells of S. aureus wild type and alsS mutant.
Beta-lactam antibiotics methicillin and oxacillin were added
to bacterial cell suspensions in a concentration range of
2–32 µg mL−1. Plates were incubated at 37◦C and 90 rpm, for
18 h. The antibiotic concentration of the first well of the series
with no sign of visible growth was considered the MIC value.
Statistics
Statistical analyses were performed using GraphPad Prism
(GraphPad software version 5.01, San Diego, CA, United States).
Results were compared using two tailed unpaired Student’s
t-tests with a confidence interval of 95%. Growths, metabolite
quantification, macrophage assays, and MICs were performed
at least in triplicate (at least three biological independent
experiments). All data is presented as mean ± standard error of
the mean (SEM).
RESULTS
Analysis of the End Products Profile of
Galactose-Grown S. aureus NO-Stressed
Cells
The hexoses, glucose and galactose are two main glycolytic
carbon sources that S. aureus has available in the nasal cavity
where the NO levels are high. In this work, we have determined
the resistance to nitrosative stress of S. aureus grown on galactose
and observed that, similar to glucose, spermine-NONOate
(250 µM) decreased the growth rate by ∼2-times, and that
higher concentrations of spermine-NONOate (500 µM) caused
no further decrease (Supplementary Figure S1). These results
show that the resistance of S. aureus to high concentrations of
NO is similar for cells grown on galactose or on glucose.
To elucidate how S. aureus sustains the nitrosative stress,
the metabolic state of S. aureus grown on galactose and
exposed to NO was studied by 1H-NMR quantification of
the glycolytic carbon source consumption, the citrate uptake
from the growth medium to feed the TCA cycle, and the
excreted end products, namely those formed downstream of
the pyruvate node (Figure 1). For comparison purposes, cells
grown on glucose were also analyzed. Thus, supernatants were
collected from cells cultured without glycolytic substrate, with
either glucose or galactose, treated with 250 µM spermine
NONOate, and analyzed 1 and 3 h after the addition of the
NO compound (Figures 2A–C). Control samples of untreated
cells were collected at the exponential phase as their metabolism
remained essentially unchanged due to a quasi steady-state
observed at this growth stage (data not shown).
In the absence of a glycolytic substrate, the 1H-NMR profile
indicated that S. aureus excreted almost exclusively acetate, in
amounts that did not vary significantly upon exposure to NO
(Figure 2A).
In S. aureus cells cultured on glucose and stressed with NO,
the consumption of glucose was more accentuated at the earlier
times of NO treatment (after 1 h) (Figure 2B). Moreover, short
exposure of cells to NO induced a considerable accumulation
of L-lactate (Figure 2B), together with very small quantities of
ethanol (Supplementary Table S2). Between 1 and 3 h after the
NO pulse, a small increase of the lactate concentration in the
extracellular medium (from 1.6 ± 0.4 mM to 2.4 ± 0.5 mM)
(Supplementary Table S2), and a decrease of the normalized
lactate concentration was observed (Figure 2B). These alterations
may result from the reduction of the lactate dehydrogenase LDH
activity and/or higher consumption of lactate by lactate-quinone
oxidoreductase LQO (Figure 1) in NO treated cells, as it was also
observed by Spahich et al. (2016).
The spectra of supernatants collected after 3 h of NO
stress showed peaks for pyruvate, α-acetolactate (generated from
the condensation of two molecules of pyruvate), acetoin and
2, 3-butanediol (Figure 2B), the last three being products of ALS
(encoded by alsS), α-acetolactate decarboxylase ALDC (encoded
by budA) and acetoin reductase AR (encoded by butA) activity,
respectively (Figure 1). Interestingly, such a pattern was not
observed in cells that were not subjected to NO stress (Figure 2B).
In addition, the acetate accumulated in untreated cells, and the
end products measured at 1 and 3 h after the NO addition do not
account for all the glucose consumed.
The citrate consumption from the glucose-containing
medium was also evaluated and the results showed that citrate
utilization initially increased after the NO pulse, followed by
a decrease after 3 h of stress (Figure 2D). This result may be
interpreted considering that at the onset of the NO stress, the
carbon flow in the TCA cycle is higher and the pyruvate, resulting
from glucose catabolism, is not only converted to end products
but is also diverted to the TCA cycle (Figures 1, 2).
On galactose, unstressed S. aureus cells excreted mainly acetate
(Figure 2C) and minor amounts of ethanol (Supplementary
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FIGURE 2 | Extracellular metabolite profile of S. aureus exposed to NO. Substrate consumed and major end products accumulated by S. aureus grown in CDM and
(A) with no glycolytic carbon source, (B) 20 mM glucose, (C) 20 mM galactose, in the absence of NO (control, Ctr) and 1 and 3 h after the addition of NO. Color
code of bars of graphs A, B, and C: black, sugar consumed; white, acetate; gray, lactate; horizontally striped, formate; vertically striped, pyruvate; right transversally
striped, α-acetolactate; black squares, acetoin and left transversally striped, 2,3-butanediol. (D) Citrate consumption by S. aureus grown with no glycolytic carbon
source (light gray bars), on glucose (white bars) and on galactose (gray horizontally striped bars), in the absence of NO (control, Ctr) and treated for 1 and 3 h with
NO. The concentrations represented in Y-axis are normalized to OD600. Error bars represent mean ± SEM (n = 3). Asterisks represent statistically significant data
relative to the control; ∗P < 0.05, ∗∗P < 0.01, and ∗∗∗P < 0.0001.
Table S2). In the presence of NO, cells doubled the galactose
consumption and excreted higher amounts of acetate
(Figure 2C). For longer times of exposure to NO, the galactose
consumption did not vary significantly and a meaningful
(P-value, 0.0130) decrease of the acetate produced occurred
together with a slight accumulation of formate (Figure 2C).
In contrast to what was observed on glucose, cells grown on
galactose did not accumulate pyruvate, α-acetolactate, acetoin,
and 2,3-butanediol (Figure 2C). Moreover, no production of
lactate was detected, which is in agreement with the requirement
of glucose for the activation of lctE (encoding LDH) (Crooke
et al., 2013).
Also on galactose, cells prolonged exposed to NO showed no
major alteration of the total extracellular concentration of acetate
[2.7 ± 0.6 mM (1 h) and 2.7 ± 0.8 mM (3 h)] (Supplementary
Table S2) and of galactose consumed (Figure 2C), which suggests
a metabolic constraint at the level of phosphotransacetylase
(PTA)/acetate kinase (ACK) and/or acetate consumption. This
impairment may lead either to the conversion of pyruvate into
α-acetolactate or to an increase of the TCA cycle flux (Sadykov
et al., 2013) (Figure 1). Cells grown on galactose in the absence
of stress or NO-treated for 3 h showed similar consumption of
extracellular citrate (Figure 2D), which reinforces the hypothesis
toward the formation of α-acetolactate through ALS (Figure 1).
After 1 h of the NO pulse, cells accumulated citrate (0.11 ± 0.02,
concentration normalized to OD600), indicating a reduction of
the TCA cycle activity. Additionally, S. aureus cells submitted
to NO for 1 h contained an extracellular acetate content higher
than that expected on the basis of the galactose consumed
(Figure 2C). This result may be due to the utilization of
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FIGURE 3 | Uptake of amino acids by S. aureus cells exposed to NO. Uptake of alanine (A), isoleucine (B), and valine (C) by S. aureus grown in CDM with no
glycolytic carbon source (black bar), on glucose (white bar) or on galactose (gray bar), in the absence (Ctr), and treated with NO, for 1 and 3 h. Error bars represent
mean ± SEM (n = 3). Asterisks represent statistically significant data relative to the control; ∗P < 0.05 and ∗∗P < 0.01.
non-glycolytic/gluconeogenic carbon sources such as amino
acids (Figure 1). We also observed that after 3 h of the NO pulse,
the extracellular content of end products (acetate and formate)
did not account for all the galactose consumed.
Overall, our results show that during prolonged exposure to
NO, S. aureus grown on galactose exhibits an unprecedented
metabolic behavior when compared with that previously reported
for cells grown on glucose and long exposed to NO.
RNA-Seq of S. aureus Grown on
Galactose and Exposed to NO
To further elucidate the metabolic behavior of S. aureus on
galactose during prolonged NO exposure, a RNA-Seq analysis
was done using RNA extracted from cells grown on galactose
and submitted to 250 µM spermine NONOate for 3 h.
Following data acquisition, the RNA-Seq results were analyzed
using the T-Rex pipeline web tool http://genome2d.molgenrug.
nl/index.php/rnaseq-expression-analysis (de Jong et al., 2015)
(Supplementary Table S3), and the data validated by quantitative
real-time RT-PCR (Supplementary Table S4).
Exposure of S. aureus to NO altered significantly the
expression of approximately 514 genes (fold-differences ≥ 2
and ≤ 0.5 with adjusted P-values ≤ 0.05), which represents
approximately 19% of the whole genome. Of these, 213 genes
were upregulated (8%) and 301 genes were downregulated
(11.4%) (Supplementary Table S3 and Figure S2).
To further interpret the data, a Gene Set Enrichment
Analysis (GSEA) of the modified genes was performed, using
the pipeline web tool http://pepper.molgenrug.nl/index.php/
gsea-pro (GSEA-Pro, MolGen, RUG). This analysis showed
that among the upregulated genes involved in central carbon
metabolism, the majority are related with metabolic processes
and catalytic activities, such as the amino acid and pentose
phosphate metabolisms (Supplementary Table S5). The more
over-represented classes include genes involved in glycine, serine
and threonine metabolism, intracellular trafficking, secretion and
vesicular transport and iron transport, storage and homeostasis
(Supplementary Table S5).
Amongst the most induced genes belonging to the amino
acid transport and metabolism categories were those involved
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FIGURE 4 | A correlation matrix of selected genes. Correlation of selected genes of classes differently expressed on S. aureus cells grown on galactose and under
NO stress as determined by the T-Rex pipeline (de Jong et al., 2015). Genes with significant correlation are colored dark blue, genes showing good anti-correlation
are colored red and uncorrelated genes are colored gray. SAUSA300_0152 (cap5A), SAUSA300_0159 (cap5H), SAUSA300_2597 (cap1B), SAUSA300_2598
(cap1A), SAUSA300_0220 (pflB), SAUSA300_0226-28 (fadBDE), SAUSA300_0235 (lctE), SAUSA300_0885-6 (fabHF ), SAUSA300_1123-4 (fadDG),
SAUSA300_1641 (gltA), SAUSA300_1454 (zwf ), SAUSA300_1725 (taI), SAUSA300_2443 (gntK), SAUSA300_2166 (alsS), SAUSA300_2444 (gntR),
SAUSA300_2008 (ilvN), SAUSA300_1225 (thrA), SAUSA300_1214 (gLY1), and SAUSA300_0445 (gltB).
in the synthesis of the gluconeogenic amino acid threonine
(Halsey et al., 2017) (thrA, asd, dhoM, thrB, thrC) that were
strongly upregulated (∼10-fold). The genes for the synthesis
of other gluconeogenic amino acids, such as glycine (gLY1),
glutamate (gltB, gltD) and the BCAAs valine and leucine (ilvN)
(Supplementary Table S3) were also upregulated, although to
a lesser extent. In contrast, NO caused the downregulation of
genes involved in respiration, namely those encoding the ATP
synthesis, hydrolysis coupled proton transporters, the respiratory
electron transport chain and cytochromes (Supplementary
Table S3). Other pathways were also altered: (i) the TCA cycle,
as judged by the upregulation of the citrate synthase gltA
(2.2-fold) gene; and (ii) the PPP, by the induction of the genes
glucose 6-phosphate 1-dehydrogenase zwf (2.1-fold), gluconate
kinase gntK (2.2-fold) and transaldolase taI (2.9-fold). Overall,
these results suggest that cells of S. aureus using galactose and
exposed to NO rely on the synthesis of gluconeogenic amino
acids and gluconeogenic processes to support growth on the
slow-metabolizing galactose.
D-glutamate, generated from L-glutamate by the activity of
glutamate racemase (murI), and glycine are cell wall constituents,
and BCAAs are precursors of membrane branched-chain fatty
acids (BCFA). We observed that genes coding for cell wall,
membrane and envelope biogenesis related proteins were
significantly induced (Supplementary Table S5). Of note was
the induction of genes involved in the synthesis of capsule
cap5 (2.1-fold), in adherence and nasopharyngeal colonization,
such as sasF (3.9-fold), sdrC (12.3-fold), and sdrD (2.5-fold)
(Supplementary Table S3) (Edwards et al., 2012). The modified
transcription was also observed for the genes involved in
the fatty acid metabolism, namely the fatty acid degradation
genes fadXEDBA (23-fold), the fatty acid biosynthesis genes
fabHF (4-fold) and fabDG (2.5-fold) (Supplementary Table S3).
Altogether, the data suggest that cells of S. aureus using galactose
and exposed to NO change their membrane composition to adapt
to the new conditions.
The expression of several iron-regulated genes was induced,
including that of ftn (14.3-fold) and feoA (4.1-fold) that code
for a non-heme ferritin family protein and the ferrous iron
transport protein A, respectively, and that of the siderophore
biosynthesis gene sbnA (2.2-fold) (Supplementary Table S3). On
the contrary, the methionine biosynthesis genes metCFE
exhibited down-regulation of approximately 2.5-fold
(Supplementary Table S3). Interestingly, the iron-regulated
genes and methionine biosynthesis genes that were differentially
expressed in S. aureus, when grown on galactose and under
prolonged NO stress, exhibited trends similar to those observed
in the transcriptome of S. aureus done on samples collected from
the anterior nares (Chaves-Moreno et al., 2016).
Several transcriptional regulators had their expression
modified, namely TetR, MerR, ArgR, GntR, and DeoR
(Supplementary Table S3). The cidR gene was also upregulated
by NO, cidR encodes a LysR-type family regulator that controls
the cidABC and alsS/budA operons (Supplementary Table S3).
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FIGURE 5 | NADP+/NADPH ratio of S. aureus NO-stressed cells. S. aureus
was grown in CDM with no glycolytic carbon source (black bars), on glucose
(white bars), and on galactose (gray bars) in the absence (Ctr) and under NO
stress for 3 h. Error bars represent mean ± SEM (n = 3). Asterisks represent
statistically significant data relative to the control; ∗P < 0.05.
In accordance, the upregulation of alsS/budA was observed and
confirmed by quantitative real-time RT-PCR (Supplementary
Tables S3, S4). Interestingly, our previous work also showed that
S. aureus cells grown on glucose and exposed to GSNO had
high induction of alsS (∼16-fold) (Nobre and Saraiva, 2013),
indicating that ALS confers resistance to NO independently of
the sugar source.
Genes involved in the pyruvate metabolism were affected such
as the lactate dehydrogenase lctE gene that had its transcription
decreased, a pattern that is similar to that observed in cells grown
on glucose in the presence of GSNO (Nobre and Saraiva, 2013).
Also downregulated were the genes coding for the
PFL (∼3-fold) and eutD encoding phosphotransacetylase
(PTA) (∼2-fold), which is the first enzyme of the acetate
pathway (Supplementary Table S3 and Figure 1) (Halsey et al.,
2017).
Altogether, the modifications induced by prolonged NO
exposure on the genes encoding proteins acting downstream of
the pyruvate node were consistent with the metabolic profile
determined by the 1H-NMR experiments (Figure 2C).
The growth of S. aureus on galactose caused high induction
of the cap5A, sdrC, thrA, and fadE genes that are linked to
cell wall components, amino acid and fatty acid metabolism.
This behavior contrasts with what was observed for cells grown
on glucose (Supplementary Table S4), therefore, suggesting a
specific galactose-linked response. The alsS/budA operon was
upregulated both on galactose- and glucose-grown S. aureus cells
subjected to prolonged NO stress (Supplementary Table S4),
indicating that alsS is important independently of the glycolytic
carbon source utilized. Moreover, this response is related to a
prolonged exposure to NO, as galactose-grown cells exposed to
1 h of NO stress caused the downregulation of the alsS and budA
genes (0.4± 0.0 and 0.6± 0.2, respectively), while the expression
of these genes did not vary significantly in glucose-grown cells
(data not shown).
Taken together, the RNA-Seq and qRT-PCR data indicate that
when S. aureus uses galactose and has prolonged exposure to
NO stress, alsS is highly upregulated as well as the genes for the
biosynthesis of gluconeogenic amino acids, such as threonine.
Moreover, the gluconeogenic processes and the biosynthesis of
gluconeogenic amino acids are activated.
Amino Acid Metabolism of S. aureus
under NO Stress
As mentioned above, the genes involved in the class of amino
acid transport and metabolism were highly induced in NO
treated S. aureus galactose-grown cells (Supplementary Table S3).
Therefore, we performed the quantification by 1H-NMR of
the extracellular amino acids, and the results showed that
under these conditions cells had a considerable consumption of
alanine, and a slightly higher consumption of BCAAs, such as
isoleucine and valine (Figure 3), but suffered depletion of glycine,
glutamate and threonine (Supplementary Figure S3). It was also
seen higher accumulation of isovaleric acid and 2-ketobutyric
acid (Supplementary Figure S4), which are products of leucine
and valine degradation, respectively, most possibly due to an
increased requirement of acetyl-CoA.
Amino acid biosynthesis requires the cofactor NADPH, whose
major intracellular source is the PPP that is also used for the
production of fatty acids and nucleic acids. A matrix analysis
of the RNA-Seq data indicated a high correlation among the
PPP genes (zwf SAUSA300_1454, taI SAUSA300_1725, gntK
SAUSA300_2443) and amino acid biosynthesis genes (gntR
SAUSA300_2444, ilvN SAUSA300_2008, thrA SAUSA300_1225,
gLY1 SAUSA300_1214, gltB SAUSA300_0445) (Figure 4). Since
the reactions of the PPP are dependent on NADP+, the
NADP+/NADPH ratio was determined. Interestingly, following
3 h of NO pulse, cells grown on galactose exhibited a significantly
lower NADP+/NADPH ratio when compared with cells using
glucose (Figure 5), indicating that the utilization of galactose
increases the metabolic activity of the PPP. A similar behavior
was reported for S. aureus exposed to oxidative stress, as these
cells had higher activity of the PPP and elevated NADPH
concentrations (Deng et al., 2014).
ALS in S. aureus Protects against NO
Stress
The metabolic profile of S. aureus suggests that prolonged
exposure to NO of cells grown on galactose leads to an increase
of the ALS activity. Consistent with these results, we observed
higher expression of the alsS gene and of the genes involved in
BCAAs biosynthesis whose precursor is alpha-acetolactate, the
product of the ALS activity. Thus, we speculated that ALS was
most possible one of the enzymes used to replenish the need
for amino acids of cells grown on galactose and under extensive
NO stress. To test this hypothesis, a S. aureus alsS mutant was
studied regarding the growth behavior and metabolic response
of stressed galactose-grown cells. For comparison purposes,
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FIGURE 6 | Growth of S. aureus wild type and alsS mutant exposed to NO. S. aureus wild type (♦,1) and alsS mutant (, ) were cultured in CDM (A),
supplemented with 20 mM glucose (B) or with 20 mM galactose (C), and in nasal-like synthetic medium containing 10 mM glucose (D). Cells were grown under
aerobic conditions in the presence (1, ) or absence (♦,) of NO, which was added at OD600 of 0.4. Points represent the average of at least four independent
assays.
cells cultured on glucose were also analyzed. The alsS mutant
grown on either sugar and treated with NO showed a decrease
of the final biomass relative to the parental strain (1.5-fold),
which was not observed in the absence of a glycolytic substrate
(Figures 6A–C). However, in all cases, the growth rates were not
significantly affected (Figures 6A–C), thus suggesting that when
using glucose or galactose the strain lacking alsS enters earlier
into the post-exponential phase (Figures 6B,C).
Concerning the end products profile, the S. aureus alsS mutant
grown on a glycolytic carbon source-free medium had only a
slight increase of the acetate content relative to that of the wild
type independently of the NO treatment (Figure 7A).
When cultured on glucose, unexposed alsS mutant cells
had slightly higher content of acetate than the wild type,
and presented minor amounts of lactate (Figure 7B). The
end products concentration in the alsS mutant cells fully
accounted for all the glucose consumed. In the absence of
NO, the alsS mutant produced approximately 5 mM/OD600 of
acetate and lactate from the consumption of 2.5 mM/OD600
of glucose. After 3 h of NO stress, the alsS mutant contained
approximately two-times more acetate and pyruvate than the
wild type, while no accumulation of α-acetolactate, acetoin
and 2,3-butanediol was observed, indicating that α-acetolactate
is produced by the activity of ALS enzyme (Figure 7B).
Moreover, the concentration of the end products accounted all
the glucose consumed (∼6.3 mM/OD600 of acetate, 1 mM/OD600
of lactate, and 0.5 mM/OD600 of pyruvate were excreted
when 3.9 mM/OD600 of glucose was consumed). This result
suggested that the TCA cycle in the alsS mutant is not active,
at least to a great extent, which is in agreement with the
accumulation of citrate in the extracellular medium rather
than consumption (Figure 7D). When compared with the
wild type, the 3 h NO-treated glucose-grown alsS mutant
cells accumulated extracellularly approximately the double
amount of acidic end products (Figure 7B). This data
suggest that under these conditions the mutant had a lower
intracellular pH level (Thomas et al., 2014), which is consistent
with a premature entering into the post-exponential phase
(Figure 6B).
On galactose, inactivation of alsS generated cells that in
the NO-free environment contained similar levels of acetate,
but consumed two-times less galactose than the wild type
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FIGURE 7 | Metabolite profile of S. aureus alsS mutant upon exposure to NO. Metabolites evaluated in S. aureus grown in the absence of a glycolytic carbon source
(A) and in media containing 20 mM glucose (B) or 20 mM galactose (C), which remained untreated (control, Ctr) or were exposed to NO, for 3 h. Color code of bars
of graphs A, B, and C: white, acetate; black, sugar consumed; gray, lactate; horizontally striped, formate; vertically striped, pyruvate. In (D) is depicted the citrate
accumulation in cells grown with no glycolytic carbon source (light gray bar), on glucose (white bar) and on galactose (gray horizontally striped bar) untreated
(control, Ctr) and exposed to NO for 3 h. For each end product, the ratio between the concentrations in the alsS mutant divided by that of the wild type cells is
represented. Error bars represent mean ± SEM (n = 3). Asterisks represent statistically significant data relative to the control; ∗P < 0.05 and ∗∗∗P < 0.0001.
(Figure 7C). Furthermore, the alsS mutant had an increased
amount of acetate and formate end products (4.5 mM/OD600),
than those expected from the consumption of 0.5 mM/OD600
of galactose, which contrasts with the total carbon recovery
observed on glucose. When exposed to NO, the alsS mutant
had a threefold higher accumulation of acetate and a slightly
lower amount of formate than the parental strain (Figure 7C).
These results indicate that a strain inactivated in alsS and exposed
to NO does not produce α-acetolactate and its derivatives, but
instead leads to a higher accumulation of acidic end products
(Figure 7C).
When treated with NO, S. aureus cells grown on galactose
contained no acetoin and 2,3-butanediol. Moreover, the mutation
of alsS increased the acetate content. Therefore, the derived
compounds of α-acetolactate present in the wild type strain are
most probably BCAAs as α-acetolactate is also a known precursor
of the BCAAs synthesis (Figure 1) (Goupil-Feuillerat et al., 1997).
Hence, we conclude that under NO stress, the ALS activity
plays an important role by preventing extracellular acetate
accumulation through the production of α-acetolactate for the
biosynthesis of BCAAs, which counteracts the pH stress imposed
by the higher content of acetate.
The Effect of the ALS Inactivation in
S. aureus Grown on a Nasal-Like
Synthetic Medium
Previously, Krismer et al. (2014) described a nasal synthetic
medium that was considered similar to the in vivo environment
experienced by S. aureus inside the human nose. Similar to
our transcriptome data, the global gene expression analysis
of S. aureus grown on the nasal-like medium showed a
significant upregulation of amino acid biosynthesis genes
of glutamate, valine and leucine, and iron transporters
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FIGURE 8 | Metabolite profile of the alsS mutant grown on nasal synthetic medium exposed to NO. Cells of wild type (wt) and alsS mutant grown in nasal synthetic
medium untreated (A) and exposed to NO for 1 h (B) and 3 h (C) were analyzed. Black bar, glucose consumed; white bar, acetate accumulated; gray bar, lactate
accumulated; vertically striped bars, pyruvate consumed (below 0) or accumulated (above 0). Error bars represent mean ± SEM (n = 3). Asterisks represent
statistically significant data relative to the wild type; ∗P < 0.05.
FIGURE 9 | Uptake of amino acids and succinate by the S. aureus alsS mutant grown in nasal synthetic medium and subjected to NO. Uptake of valine (black bar),
alanine (white bar), and succinate (gray bar) by wild type (wt) and alsS mutant strains, untreated (A) and exposed to NO for 1 h (B) and 3 h (C). Error bars represent
mean ± SEM (n = 3). Asterisks represent statistically significant data relative to the wild type; ∗∗∗P < 0.0001.
(Krismer et al., 2014). Therefore, metabolic studies on cells
grown on the nasal-like synthetic medium were also done. To
note that when compared with the CDM, the nasal-like synthetic
medium contains lower amount of amino acids (∼2-fold
lower concentration), and lacks several amino acids, namely,
aspartate, methionine, trans-hydroxyproline, and isoleucine.
Furthermore, the medium contains fumaric, maleic, pyruvic
and succinic acids and urea, which are absent from the CDM
medium. Also, the citric acid and glucose concentrations are
lower by 50- and 2-fold, respectively, and no folic acid is
present.
We observed that S. aureus wild type grown on the nasal-like
synthetic medium accumulated high levels of acetate, which did
not account for all the glucose exhausted from the extracellular
medium, and consumed small amounts of pyruvate from the
extracellular medium (Figure 8A). After 1 h of NO stress, the
wild type cells exhibited levels of glucose utilization, similar to
those of unstressed cells, and L-lactate accumulation. However,
cells accumulated more acetate, had increased consumption of
alanine, and no pyruvate was detected (Figures 8B, 9B). Upon
prolonged exposure to NO, the lactate levels decreased and
pyruvate accumulated (Figure 8C).
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FIGURE 10 | Viability of S. aureus alsS mutant contacting with murine
macrophages. S. aureus wild type (black and gray bar) and alsS mutant cells
(white and striped bar) were incubated with activated macrophages (black
and white bar), and with L-NMMA treated macrophages (gray and striped
bar). The number of intracellular S. aureus cells were determined at the
indicated times. Error bars represent mean ± SEM (n = 3). Asterisks represent
statistically significant data; ∗P < 0.05, ∗∗P < 0.01, and ∗∗∗P < 0.0001.
Cells mutated in alsS showed a 1 mM/OD600 increase in the
acetate levels and pyruvate was accumulated instead of being
consumed, while in the wild type no accumulation of the ALS,
ALDC and AR products was observed (Figure 8A). Moreover, the
alsS mutant exhibited reduced viability and a fourfold decrease
of the valine consumption (Figures 6D, 9A), suggesting that the
ALS activity is required for the consumption of BCAAs, and that
α-acetolactate is being utilized for the BCAAs synthesis via ALS
(Figure 1).
Cells of the alsS mutant treated with NO for 1 h
consumed less alanine and accumulated more acetate
extracellularly (Figures 8B, 9B). Furthermore, for longer
times of NO exposure, the amount of pyruvate doubled and the
consumption of succinate decreased by approximately two-times
(Figures 8C, 9C).
Altogether, the NO-stressed S. aureus alsS mutant cells
presented a different metabolic pattern on the nasal-like medium,
which is most probably due to the quite different medium
composition on carbon sources and amino acids relative to CDM.
ALS Contributes to the Survival of
S. aureus in Macrophages
Taking into consideration that the alsS expression and ALS
activity are increased by NO and that inactivation of alsS
rendered the strains more sensitive to NO (Supplementary
Table S3 and Figures 2, 6B,C), we next determined the viability
of the alsS mutant when infecting murine macrophages J774A.1.
Data showed that the alsS mutant is more efficiently killed
by macrophages than the wild type (Figure 10). Similar assays
were performed with macrophages previously incubated with the
mammalian inhibitor of iNOS (L-NMMA), i.e., in macrophages
that do not release NO, which was ascertained by the lowered
concentration of extracellular nitrite (Supplementary Figure S5).
Treatment with the inhibitor reversed the loss of viability of the
alsS mutant to levels similar to those of the wild type strain
(Figure 10). Hence, we concluded that ALS promotes survival
from phagocytosis by protecting S. aureus from the innate
immune NO radical.
ALS Protects S. aureus from
Beta-Lactam Antibiotics
The matrix analysis of the RNA-Seq data indicated the occurrence
of a high correlation between alsS and fatty acid degradation
and capsular genes involved in modulation of the cell surface
(Figure 4). Thus, we questioned whether ALS could play a role
in the resistance of the MRSA to beta-lactam antibiotics, which
target the cell wall biosynthesis. For this purpose, we determined
for the S. aureus MRSA wild type and alsS mutant the MIC of
antibiotics commonly used for the treatment of the pathogen,
namely the beta-lactams oxacillin and methicillin. The results
showed that inactivation of alsS leads to a twofold decrease in
the MIC value, i.e., S. aureus becomes less resistant to these
antibiotics (Table 1).
DISCUSSION
Staphylococcus aureus has been reported to tolerate moderate
to high levels of NO when using glucose, one of the carbon
sources available in the nasal cavity. In this work, we analyzed
the behavior of S. aureus when aerobically grown on galactose,
another abundant hexose on the nasal cavity, and exposed to NO,
and compared the results with cells cultured on glucose and on a
nasal-like medium.
Staphylococcus aureus cultured on galactose exhibited
growth rate and biomass yield similar to that observed
on glucose, which indicates that the slow-metabolizing
galactose also sustains replication of the pathogen under
NO stress. However, the metabolism underpinning growth
proved to be significantly different. For example, 1 h after
the NO stress pulse, cells grown on galactose excreted more
acetate than on glucose. Moreover, the increase of acetate
excretion and accumulation of extracellular citrate, rather
than consumption, indicates a decreased flux of the TCA
cycle and respiration as these pathways rely on NO-sensitive
enzymes, such as the iron-sulfur containing aconitase and
cytochrome oxidase (McCollister et al., 2011; Richardson et al.,
2011).
TABLE 1 | Minimal inhibitory concentrations of oxacillin and methicillin against
S. aureus.
S. aureus Oxacillin Methicillin
MIC (µg mL−1)
Wild type 13 14
alsS 6 6
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The higher increase of acetate production detected for
galactose-grown cells exposed to NO for 1 h provides
S. aureus higher ATP levels that are particularly relevant
for the growth on slowly metabolized carbon sources as
was described for other bacteria (Carvalho et al., 2011).
However, prolonged NO stress caused a significant decrease
of acetate accumulation and the increased consumption of
threonine, glycine, glutamate, and BCAAs from the extracellular
medium. Additionally, RNA-Seq data showed upregulation
of genes required for the synthesis of threonine, glycine,
glutamate, BCAAs, and fatty acids degradation, and acting
in the first half of the TCA cycle and the PPP. Consistent
with these results, cells had higher content of NADPH, a
cofactor that boosts anabolic reactions. In S. typhimurium, the
first enzyme of the PPP glucose 6-phosphate dehydrogenase
(G6PDH) was shown to provide reducing equivalents in the
form of NADPH and to have an important role in the
defense against nitrosative stress by maintaining the cellular
redox state, regenerating reduced thiols, and repairing oxidative
or nitrosative damage (Lundberg et al., 1999). When using
galactose, but not glucose under prolonged NO stress, S. aureus
showed higher demand of amino acids. Interestingly, similar
behavior was also observed for NO-stressed cells grown
on the gluconeogenic substrate L-lactate (Spahich et al.,
2016).
When S. aureus grows on glucose, the exposure to NO does
not alter the amount of excreted acetate but causes the increase
of the lactate levels, which decrease under prolonged stress.
Although these results apparently differ from those previously
reported for S. aureus showing that in cells treated for 4 h with
NO there is a strong increase of lactate and acetate is absent,
it should be noted that the metabolite production at earlier
times was not analyzed and much higher concentrations of NO
were used, conditions that completely inhibit the activities of the
PDHC and PFL enzymes (Richardson et al., 2008). Moreover,
the contrasting effects of NO on S. aureus grown on galactose
versus glucose may be a consequence of the slower glycolysis,
and such behavior is expected to also occur when S. aureus
uses other slow-metabolizing sugars available in its colonization
niche.
Transcriptomic analysis revealed that NO induces the
expression of the catabolic alsS/budA and butA genes that
encode ALS/ALDC and AR proteins. These gene products are
generally regarded as involved in the synthesis of non-acidic
products acetoin and 2,3-butanediol and regeneration of NAD+
(Goupil-Feuillerat et al., 1997; Thomas et al., 2014). Considering
that butanediol fermentation is activated when S. aureus shifts
from aerobic to anaerobic growth (Fuchs et al., 2007), the
sensitivity of the alsS mutant strain to NO could derive from
an indirect consequence of the inhibition of respiration by NO.
However, our data do not support this hypothesis, as we did
not observe higher expression of the genes that are usually
induced when S. aureus grows under anaerobic conditions,
such as adhE, adh, narH, narI, narJ, pfl and genes encoding
glycolytic enzymes (Fuchs et al., 2007). Moreover, the higher
induction of alsS occurred 3 h after the NO pulse, which is when
the NO inhibitory effect of respiration is expected to be less
prominent considering the half-life of the spermine NONOate
(∼40 min).
A previous study reported that the alsS/budA operon is
activated by the CidR regulator. The gene encoding CidR was
also induced in our RNA-Seq study. CidR has been proposed
to be activated by a decrease of the intracellular pH, mainly by
accumulation of acetic acid (Thomas et al., 2014). In accordance,
increased levels of extracellular acidic levels were observed
upon exposure of S. aureus to NO. Moreover, α-acetolactate,
acetoin and 2,3-butanediol, which are the products of the ALS
and ALDC/AR activities, were observed on glucose-grown cells
under prolonged NO stress. The accumulation of butanediol
occurred after a short exposure (20 min) to the NO donor
MAHMA NONOate (500 µM) for S. aureus COL grown on a
glucose-containing medium (Hochgräfe et al., 2008). The absence
of α-acetolactate, acetoin and 2,3-butanediol in NO-stressed
galactose-grown cells may be due to the higher requirement
for BCAAs and the increased levels of NADPH that were
observed under these conditions, which shifts the product of ALS
activity, α-acetolactate, to the production of BCAAs (Figure 11).
Interestingly, it was reported for the Gram-positive Lactococcus
lactis that under BCAAs starvation there is a relief of the
allosteric activation of ALDC by BCAAs, and of the allosteric
inhibition of the BCAAs synthesis pathway (Goupil-Feuillerat
et al., 1997). Moreover, BCAAs serve also as precursors for
membrane BCFAs and were shown to be important for pH stress
tolerance (Kaiser et al., 2016). Alternatively, the requirement
for BCAAs may be related with the inhibition by NO of the
dihydroxyacid dehydratase enzyme (coded by ilvD and involved
in the BCAAs biosynthesis), similarly to what was observed
for the dihydroxyacid dehydratase of Escherichia coli (Hyduke
et al., 2007). In accordance with the requirement of S. aureus for
BCAAs when growing on galactose under prolonged exposure to
NO stress, there was a small but significantly higher consumption
of the BCAAs valine and isoleucine. The threefold higher
accumulation of acetate in the alsS mutant strain suggests that
ALS directs the metabolism toward the BCAAs production
by fuelling pyruvate resulting from galactose breakdown into
α-acetolactate production (Figure 11). BCAAs were shown to
be important for the virulence of S. aureus (Kaiser et al.,
2016), i.e., under conditions where NO is generated by the host
cells. Furthermore, the S. aureus CodY transcriptional regulator,
that represses several amino acid biosynthetic pathways when
intracellular BCAAs and GTP are available (Majerczyk et al.,
2010), has been associated with NO resistance and implicated
in virulence (Majerczyk et al., 2010; Grosser et al., 2016).
Interestingly, a great number of genes that were transcriptionally
modified in our RNA-Seq analysis are regulated by CodY,
namely threonine, ilvBN, and glutamate and capsule synthesis
genes.
Contrary to the wild type, the S. aureus alsS mutant cells did
not consume citrate but excreted it to the extracellular medium,
which indicates impairment of the TCA cycle. Furthermore,
the mutant cells accumulated higher levels of acetate, especially
on galactose-containing medium, which may explain the lower
survival of the mutant strain (Figure 6C). Consistent with our
data, Thomas et al. (2014) reported that the S. aureus alsS/budA
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FIGURE 11 | Schematic representation of the central metabolic pathways of S. aureus grown on galactose and prolonged exposed to NO. Upregulated and
downregulated pathways (cut-off > 2) are denoted with bold green and red arrows, respectively. Narrower green and red arrows indicate significantly altered
expression, considering a cut-off between 1.5 and 2. The α-acetolactate synthase (alsS) and the NADP+, NADPH cofactors are highlighted in black and blue,
respectively. Proposed pathways were reconstructed based on genome information (http://www.ncbi.nlm.nih.gov/genomes/lproks.cgi), literature and database
surveys (KEGG, MetaCyc). BCAAs, branched-chain amino acids; BCFAs, branched-chain fatty acids; FA, fatty acids.
mutant had an accrual of extracellular acetate that results in
increased cell death linked to ROS accumulation. Moreover,
we observed that the valine consumed upon alsS inactivation
lowered significantly (data not shown), suggesting that ALS may
be required for the consumption of valine, an issue that requires
future detailed analysis.
The alsS mutant had lower survival within macrophages, and
inhibition of the mammalian NO synthase lifted the growth
impairment. This result points to a NO-related protective role for
ALS and is in line with the high expression of alsS in samples
collected from human nares that contain significant NO levels
(Chaves-Moreno et al., 2016).
In the nasal-like medium, the cellular consumption of glucose
did not change significantly upon 1 h of NO exposure; however,
the pyruvate (present in the medium at high concentrations
of 300 µM) was completely utilized and alanine was more
consumed. Contrary to what was observed in cells grown
in CDM, in the nasal-like medium, pyruvate was consumed
instead of glucose to produce lactate for balancing the reducing
equivalents (NAD+) (Figures 2B, 8B).
In nasal-like medium, alsS proved also to have an important
role as its inactivation causes growth defects. Additionally,
the absence of quantifiable amounts of the products of the
ALS activity, namely α-acetolactate, acetoin and 2,3-butanediol,
indicate a requirement for BCAAs in the nasal medium, which
may be due to the absence of isoleucine and the low levels of
leucine and valine present in this medium (Krismer et al., 2014).
CONCLUSION
We show how S. aureus copes with prolonged NO stress when
metabolizing a slow-sugar like galactose, that is one of the main
hexoses available in the nasal cavity. The following model is
therefore proposed (Figure 11): NO promotes the formation of
acetyl-CoA, which feeds acetyl molecules into the first half of
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the TCA cycle, and the synthesis of amino acids (e.g., glutamate,
threonine, glycine, BCAAs), which are also boosted by the
NADPH produced by the upregulated genes of the PPP. Among
the genes products involved in amino acid synthesis, one
of the most upregulated is that encoding ALS. Under NO
stress, ALS seems to have a dual role by preventing acid
stress and promoting the synthesis of BCAAs (Figure 11).
Furthermore, this study disclosed the role of ALS in the
resistance of S. aureus, by showing that ALS contributes not
only to NO resistance but also to the resistance to antibiotics
commonly used against S. aureus, such as methicillin and
oxacillin.
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